Which has the lower trailing P/E, BSX or COR?

BSX has the lower trailing P/E: BSX trades at 17.83 and COR at 24.02. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or COR?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus COR at 10.25%.

Does BSX or COR pay a bigger dividend?

COR pays a dividend (0.75% yield), while BSX has no payments in the available dividend history.

Is BSX or COR more profitable?

BSX runs the higher net margin — BSX at 17.47% versus COR at 0.79%.

How have BSX and COR total returns compared?

Over the past 10 years, BSX delivered 6.22% and COR delivered 16.42% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Cencora, Inc. (COR)

A side-by-side comparison of Boston Scientific Corporation and Cencora, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$65.21B

$43.87HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

COR

Cencora, Inc.

$62.90B

$323.29HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

Total return — BSX vs COR

growth of $100 · dividends reinvested · last 10y

BSX +82.8% (+6.2%/yr)COR +347.2% (+16.2%/yr)COR compounded faster over this window

BSX COR

BSX vs COR: by the numbers

•BSX is the larger company ($65.21B vs $62.90B market cap).
•BSX trades at the lower trailing earnings multiple (17.83 vs 24.02 P/E), one valuation lens rather than an overall verdict.
•BSX converts more revenue to profit (17.47% vs 0.79% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 10.25% CAGR).
•COR pays a dividend (0.75% yield), while BSX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BSX	COR
P/E ratio	17.83	24.02
Forward P/E	13.34	18.09
P/S ratio	3.11	0.19
P/B ratio	2.62	20.62
EV / EBITDA	13.33	13.33
FCF yield	5.56%	6.45%

Profitability

Metric	BSX	COR
Gross margin	71.16%	3.71%
Operating margin	21.46%	1.30%
Net margin	17.47%	0.79%
ROE	14.71%	86.03%
ROIC	10.57%	12.75%

Dividends

Metric	BSX	COR
Dividend yield	N/A	0.75%
Payout ratio	N/A	17.83%

Growth (annualized)

Metric	BSX	COR
Revenue CAGR (5Y)	13.40%	10.25%
EPS CAGR (5Y)	N/A	11.97%
FCF CAGR (5Y)	15.64%	9.63%
Total return CAGR (5Y)	-0.67%	22.96%

Frequently asked

Which has the lower trailing P/E, BSX or COR?: BSX has the lower trailing P/E: BSX trades at 17.83 and COR at 24.02. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or COR?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus COR at 10.25%.
Does BSX or COR pay a bigger dividend?: COR pays a dividend (0.75% yield), while BSX has no payments in the available dividend history.
Is BSX or COR more profitable?: BSX runs the higher net margin — BSX at 17.47% versus COR at 0.79%.
How have BSX and COR total returns compared?: Over the past 10 years, BSX delivered 6.22% and COR delivered 16.42% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full COR analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Cencora P/E ratio Cencora dividend yield Boston Scientific ROE Cencora ROE Boston Scientific operating margin Cencora operating margin Boston Scientific revenue growth Cencora revenue growth Boston Scientific free cash flow Cencora free cash flow

Boston Scientific & Cencora appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.